The Evolving Management of Irritable Bowel Syndrome with Constipation: Pharmacists’ Key Role in Improving Outcomes (Recorded Podcast)

» References (PDF)

FACULTY

Shubha Bhat, PharmD, MS
Clinical Pharmacy Specialist, Gastroenterology
Cleveland Clinic
Cleveland, OH

LEARNING OBJECTIVES

Upon completion of this program, participants should be better able to:

• Describe irritable bowel syndrome with constipation (IBS-C), its impact on patient quality of life, current treatment options and the novel agent tenapanor
• Recognize effective approaches to promoting safe and optimal use of the novel agent for IBS-C

Back to Top